SAN DIEGO--(BUSINESS WIRE)--PURE Bioscience (OTCBB:PURE) today reported financial results for the year ended July 31, 2006. Revenues from continuing operations for the fiscal year were $200,400, compared with equivalent revenues of $155,800 in the prior year. The Company reported a loss from continuing operations before taxes of $(3,680,500), or $(0.19) per share, compared with a loss of $(3,011,800), or $(0.19) per share, in the prior year.
